BioShares Biotechnology Clinical Trials Fund — new fund registration

ETFis Series Trust I registered 2 new fund series on Form 485APOS, filed 2014-09-03. Featured series: BioShares Biotechnology Clinical Trials Fund.

Registration

• Registrant / trust: ETFis Series Trust I
• CIK: 0001559109
• Form: 485APOS
• Filed: 2014-09-03
• State of incorporation: DE
• Accession: 0000891092-14-006682
• Reported net assets: $37.3M

Series & classes (2)

Fees (from the effective prospectus)

• 12b-1 fee: 0.00%
• Gross expense ratio: 0.79%
• Management fee: 0.79%
• Other expenses: 0.00%

Investment objective

The Virtus Biotech Clinical Trials ETF (formerly, Virtus LifeSci Biotech Clinical Trials ETF) (the Fund ) seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index (the Underlying Index ).

Advisers

• Virtus Investment Advisers, LLC (Advisor)

Other filings by this registrant (15)

• 485APOS — 2026-04-14 (1 new series)
• 485APOS — 2020-05-19
• 485APOS — 2018-11-05 (1 new series)
• 485APOS — 2018-11-05 (2 new series)
• 485APOS — 2018-10-04 (1 new series)
• 485APOS — 2017-12-29
• 485APOS — 2017-07-12 (1 new series)
• 485APOS — 2017-05-22 (1 new series)
• 485APOS — 2017-04-07 (1 new series)
• 485APOS — 2016-11-21
• 485APOS — 2016-02-22 (1 new series)
• 485APOS — 2015-12-03 (1 new series)

More

• Registrant profile: ETFis Series Trust I
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search